U6Z Fundamental Analysis - URANIUM ENERGY CORP

Name: URANIUM ENERGY CORP (U6Z) Stock
Brand: URANIUM ENERGY CORP
Rating: 5.5 (3 reviews)

Fundamental Rating

Taking everything into account, U6Z scores 4 out of 10 in our fundamental rating. U6Z was compared to 68 industry peers in the Oil, Gas & Consumable Fuels industry. While U6Z has a great health rating, there are worries on its profitability. While showing a medium growth rate, U6Z is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

U6Z had negative earnings in the past year.

In the past year U6Z has reported a negative cash flow from operations.

In the past 5 years U6Z reported 4 times negative net income.

U6Z had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -7.91%, U6Z is not doing good in the industry: 82.35% of the companies in the same industry are doing better.

U6Z's Return On Equity of -8.91% is on the low side compared to the rest of the industry. U6Z is outperformed by 80.88% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.91%
ROE	-8.91%
ROIC	N/A

ROA(3y)-3.88%

ROA(5y)-3.78%

ROE(3y)-4.4%

ROE(5y)-4.27%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 36.62%, U6Z is in line with its industry, outperforming 44.12% of the companies in the same industry.

U6Z's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for U6Z so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	36.62%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.16%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for U6Z has been increased compared to 1 year ago.

U6Z has more shares outstanding than it did 5 years ago.

There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

U6Z has an Altman-Z score of 26.66. This indicates that U6Z is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of U6Z (26.66) is better than 100.00% of its industry peers.

U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	26.66

ROIC/WACCN/A

WACC8.68%

2.3 Liquidity

A Current Ratio of 8.85 indicates that U6Z has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 8.85, U6Z belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.

U6Z has a Quick Ratio of 5.85. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.

U6Z has a better Quick ratio (5.85) than 97.06% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.85
Quick Ratio	5.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -300.00% in the last year.

Looking at the last year, U6Z shows a very strong growth in Revenue. The Revenue has grown by 29737.95%.

EPS 1Y (TTM)-300%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-50%

Revenue 1Y (TTM)29737.95%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

U6Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.53% yearly.

Based on estimates for the next years, U6Z will show a very strong growth in Revenue. The Revenue will grow by 59.34% on average per year.

EPS Next Y-354.5%

EPS Next 2Y-31.03%

EPS Next 3Y59%

EPS Next 5Y57.53%

Revenue Next Year94.09%

Revenue Next 2Y31.82%

Revenue Next 3Y52.24%

Revenue Next 5Y59.34%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for U6Z. In the last year negative earnings were reported.

Also next year U6Z is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as U6Z's earnings are expected to grow with 59.00% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-31.03%

EPS Next 3Y59%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for U6Z!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

URANIUM ENERGY CORP

FRA:U6Z (11/25/2025, 5:22:43 PM)

10.11

+0.09 (+0.88%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)09-24 2025-09-24/bmo

Earnings (Next)12-02 2025-12-02

Inst Owners89.84%

Inst Owner ChangeN/A

Ins Owners1.68%

Ins Owner ChangeN/A

Market Cap4.89B

Revenue(TTM)66.84M

Net Income(TTM)-87.66M

Analysts78.46

Price Target14.4 (42.43%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-89.77%

Min EPS beat(2)-131.02%

Max EPS beat(2)-48.51%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)12.79%

PT rev (3m)72.97%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-33.33%

EPS NY rev (1m)-444%

EPS NY rev (3m)-164.76%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)8.99%

Revenue NY rev (3m)-21.23%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	84.38
P/FCF	N/A
P/OCF	N/A
P/B	5.73
P/tB	20.56
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)-0.13

FCFYN/A

OCF(TTM)-0.12

OCFYN/A

SpS0.12

BVpS1.76

TBVpS0.49

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.91%
ROE	-8.91%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	36.62%
FCFM	N/A

ROA(3y)-3.88%

ROA(5y)-3.78%

ROE(3y)-4.4%

ROE(5y)-4.27%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.16%

GM growth 5YN/A

F-Score5

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	201.1%
Cap/Sales	8.52%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	8.85
Quick Ratio	5.85
Altman-Z	26.66

F-Score5

WACC8.68%

ROIC/WACCN/A

Cap/Depr(3y)173.55%

Cap/Depr(5y)133.26%

Cap/Sales(3y)513.09%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-300%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-50%

EPS Next Y-354.5%

EPS Next 2Y-31.03%

EPS Next 3Y59%

EPS Next 5Y57.53%

Revenue 1Y (TTM)29737.95%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year94.09%

Revenue Next 2Y31.82%

Revenue Next 3Y52.24%

Revenue Next 5Y59.34%

EBIT growth 1Y-29.83%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year146.67%

EBIT Next 3Y88.81%

EBIT Next 5Y50.58%

FCF growth 1Y36.18%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y39.47%

OCF growth 3YN/A

OCF growth 5YN/A

URANIUM ENERGY CORP / U6Z.DE FAQ

What is the ChartMill fundamental rating of URANIUM ENERGY CORP (U6Z.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to U6Z.DE.

Can you provide the valuation status for URANIUM ENERGY CORP?

ChartMill assigns a valuation rating of 1 / 10 to URANIUM ENERGY CORP (U6Z.DE). This can be considered as Overvalued.

Can you provide the profitability details for URANIUM ENERGY CORP?

URANIUM ENERGY CORP (U6Z.DE) has a profitability rating of 1 / 10.

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

URANIUM ENERGY CORP / U6Z.DE FAQ

What is the ChartMill fundamental rating of URANIUM ENERGY CORP (U6Z.DE) stock?

Can you provide the valuation status for URANIUM ENERGY CORP?

Can you provide the profitability details for URANIUM ENERGY CORP?